Mesoblast

Developing and commercialising allogeneic cellular medicines to treat serious and life-threatening inflammatory diseases.

HQ location

Melbourne, Australia

Website

Launch date

2004

Employees

Market cap

Enterprise value

$1.9b

Share price

AUD2.20 MSB.AX

Company register number

109431870

Jobs

View job openings

Recent deals

https://twitter.com/mesoblast https://www.linkedin.com/company/mesoblast/

Authorizing premium user...